Back to search

Article

Fluorescence optical imaging is helpful in the decision for rituximab (RTX) re-therapy in patients with rheumatoid arthritis

2020-03-23

Abstract excerpt

<h4>Objective: </h4> To evaluate the ability of fluorescence optical imaging (FOI) Xiralite® in the prediction of RTX re-therapy in rheumatoid arthritis (RA) patients - in comparison to clinical, laboratory and musculoskeletal ultrasound (US) parameters. Patients and methods Patients with established RA were prospectively followed over one year by DAS28, patient’s global disease activity (VAS 0-100 mm), CRP and ES...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e84b2962-f7e6-5549-8121-1c1205c37f32
DOI
10.21203/rs.3.rs-18466/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fluorescence optical imaging is helpful in the decision for rituximab (RTX) re-therapy in patients with rheumatoid arthritisDOI 10.21203/rs.3.rs-18466/v1
Select a neighboring publication to make it the new centre.